TO PLACE YOURORDER CONTACT:
(kit for the preparation of technetium Tc 99m-labeled red blood cells)
Ultratag RBC imaging agent uses a sterile, nonpyrogenic, diagnostic kit for the in vitro preparation of technetium Tc 99m-labeled red blood cells.
It is approved for:
Full US prescribing information
Assembly of Ultratag RBC syringe components (7/17/2015)
EfficientThe only FDA-approved in vitro red blood cell Tc 99m labeling agent with typical tagging efficiency of ≥95%.1
ConsistentConsistently high labeling yields, even in the presence of certain medications.1,2
ConfidentExcellent target-to-background ratio1 from in vitro labeling helps in obtaining quality images.3,4
INDICATIONS AND USAGE
Ultratag RBC Kit for the preparation of Technetium Tc 99m–Labeled Red Blood Cells are used for blood pool imaging, including cardiac first pass and gated equilibrium imaging and for detection of sites of gastrointestinal bleeding.
IMPORTANT RISK INFORMATION WARNINGS AND PRECAUTIONS
USE IN SPECIFIC POPULATIONS
1. Ultratag™ RBC package insert. St. Louis, MO: Mallinckrodt, Inc.; 2005.2. Spicer JA, Hladik WB III, Mulberry WE. The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the Ultratag RBC kit. J Nucl Med Technol. 1999;27:132-135.3. Patrick ST, Glowniak JV, Turner FE. Comparison of in vitro RBC labeling with the Ultratag™ RBC kit versus in vivo labeling. J Nucl Med. February 1991;32:242-244.4. Taylor A, Schuster DM, Alazraki N. A Clinician's Guide to Nuclear Medicine. 2nd ed. Society of Nuclear Medicine, Inc. 2006;12.
Mallinckrodt, the “M” brand mark, and the Mallinckrodt Pharmaceuticals logo are trademarks of a Mallinckrodt company. Other brands are trademarks of a Mallinckrodt company or their respective owners. © 2015 Mallinckrodt.
Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.